ATE465173T1 - Verändertes vp-1capsidprotein von parvovirus b19 - Google Patents
Verändertes vp-1capsidprotein von parvovirus b19Info
- Publication number
- ATE465173T1 ATE465173T1 AT05799042T AT05799042T ATE465173T1 AT E465173 T1 ATE465173 T1 AT E465173T1 AT 05799042 T AT05799042 T AT 05799042T AT 05799042 T AT05799042 T AT 05799042T AT E465173 T1 ATE465173 T1 AT E465173T1
- Authority
- AT
- Austria
- Prior art keywords
- parvovirus
- protein
- 1capsid
- altered
- capsid protein
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/162—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14211—Erythrovirus, e.g. B19 virus
- C12N2750/14222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Virology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP04450180 | 2004-09-24 | ||
| PCT/EP2005/054771 WO2006032697A2 (en) | 2004-09-24 | 2005-09-23 | MODIFIED VPl-CAPSID PROTEIN OF PARVOVIRUS B19 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE465173T1 true ATE465173T1 (de) | 2010-05-15 |
Family
ID=35809798
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT05799042T ATE465173T1 (de) | 2004-09-24 | 2005-09-23 | Verändertes vp-1capsidprotein von parvovirus b19 |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US9573979B2 (de) |
| EP (2) | EP1791858B1 (de) |
| AT (1) | ATE465173T1 (de) |
| CY (1) | CY1110185T1 (de) |
| DE (1) | DE602005020815D1 (de) |
| ES (2) | ES2556710T3 (de) |
| PL (1) | PL1791858T3 (de) |
| PT (1) | PT1791858E (de) |
| WO (1) | WO2006032697A2 (de) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20090215879A1 (en) * | 2008-02-26 | 2009-08-27 | University Of North Carolina At Chapel Hill | Methods and compositions for adeno-associated virus (aav) with hi loop mutations |
| EP2396343B1 (de) | 2009-02-11 | 2017-05-17 | The University of North Carolina At Chapel Hill | Modifizierte virusvektoren sowie verfahren zu ihrer herstellung und verwendung |
| EP2556151A1 (de) | 2010-04-07 | 2013-02-13 | Novartis AG | Verfahren zur erzeugung von virusähnlichen parvovirus-b19-partikeln |
| EP2446898A1 (de) * | 2010-09-30 | 2012-05-02 | Laboratorios Del. Dr. Esteve, S.A. | Verwendung von Wachstumshormonen zur Verbesserung der Immunantwort bei immunsupprimierten Patienten |
| WO2012055814A1 (en) | 2010-10-25 | 2012-05-03 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Compound inducing lbpa accumulation for inhibiting cell-to-cell transmission of hiv |
| EP3854413A1 (de) | 2011-07-06 | 2021-07-28 | GlaxoSmithKline Biologicals SA | Immunogene kombinationszusammensetzungen und ihre verwendung |
| US10030052B2 (en) * | 2011-07-25 | 2018-07-24 | Glaxosmithkline Biologicals Sa | Parvovirus Vp1 unique region polypeptides and compositions thereof |
| CN116333057A (zh) | 2016-05-13 | 2023-06-27 | 4D分子治疗有限公司 | 腺相关病毒变体衣壳和其使用方法 |
| BR112020005436B1 (pt) | 2017-09-20 | 2022-08-02 | 4D Molecular Therapeutics Inc | Proteína do capsídeo de variante do vírus adenoassociado, virion do aav recombinante (raav) infeccioso, composições, composições farmacêuticas e usos de virion de raav ou de composições farmacêuticas |
| FI3717636T3 (fi) | 2017-11-27 | 2023-06-01 | 4D Molecular Therapeutics Inc | Adenoassosioidun viruksen kapsidivariantteja ja käyttö angiogeneesin estämisessä |
| US20220154211A1 (en) | 2019-02-25 | 2022-05-19 | Novartis Ag | Compositions and methods to treat bietti crystalline dystrophy |
| BR112021016501A2 (pt) | 2019-02-25 | 2021-10-26 | Novartis Ag | Composições e métodos para tratar distrofia cristalina de bietti |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0468520A3 (en) | 1990-07-27 | 1992-07-01 | Mitsui Toatsu Chemicals, Inc. | Immunostimulatory remedies containing palindromic dna sequences |
| WO1995026204A1 (en) | 1994-03-25 | 1995-10-05 | Isis Pharmaceuticals, Inc. | Immune stimulation by phosphorothioate oligonucleotide analogs |
| US6207646B1 (en) | 1994-07-15 | 2001-03-27 | University Of Iowa Research Foundation | Immunostimulatory nucleic acid molecules |
| DE69535905D1 (de) | 1994-07-15 | 2009-02-26 | Coley Pharm Group Inc | Immunomodulatorische Oligonukleotide |
| CO4600681A1 (es) | 1996-02-24 | 1998-05-08 | Boehringer Ingelheim Pharma | Composicion farmaceutica para la modulacion inmunitaria |
| EP0930893B1 (de) | 1996-10-11 | 2005-04-13 | The Regents of The University of California | Immunostimulierende oligonucleotidekonjugate |
| AU738513B2 (en) | 1997-02-28 | 2001-09-20 | University Of Iowa Research Foundation, The | Use of nucleic acids containing unmethylated CpG dinucleotide in the treatment of LPS-associated disorders |
| AU753688B2 (en) | 1997-03-10 | 2002-10-24 | Ottawa Civic Loeb Research Institute | Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant |
| AU7589398A (en) | 1997-05-19 | 1998-12-11 | Merck & Co., Inc. | Oligonucleotide adjuvant |
| WO1998052581A1 (en) | 1997-05-20 | 1998-11-26 | Ottawa Civic Hospital Loeb Research Institute | Vectors and methods for immunization or therapeutic protocols |
| DE19803453A1 (de) | 1998-01-30 | 1999-08-12 | Boehringer Ingelheim Int | Vakzine |
| JP2002510644A (ja) | 1998-04-03 | 2002-04-09 | ユニバーシティ オブ アイオワ リサーチ ファウンデーション | 免疫治療用オリゴヌクレオチドおよびサイトカインを用いる免疫系刺激のための方法および産物 |
| EP1077708A1 (de) | 1998-05-06 | 2001-02-28 | University Of Iowa Research Foundation | Methoden zur preventiven und therapeutischen behandlung von parasitären infektionen und damit verbundener krankheiten mittels cpg oligonukleotiden |
| SE520177C2 (sv) * | 1998-11-24 | 2003-06-03 | Kristina Broliden | Användning av tomma, icke-infektiösa, rekombinanta parvoviruskapsidpartiklar, eller P-antigenblockerande delar därav, för framställning av läkemedel för ihibering av hematopoietiska stamceller |
| AT408721B (de) | 1999-10-01 | 2002-02-25 | Cistem Biotechnologies Gmbh | Pharmazeutische zusammensetzung enthaltend ein antigen |
| WO2002013857A2 (en) | 2000-08-17 | 2002-02-21 | Intercell Biomedizinische Forschungs- Und Entwicklungs Ag | A vaccine which comprises at least one antigen and a cathelididin derived antimicrobial peptide or a derivative thereof |
| AT410635B (de) | 2000-10-18 | 2003-06-25 | Cistem Biotechnologies Gmbh | Vakzin-zusammensetzung |
| EP1275658B1 (de) * | 2001-07-10 | 2006-11-15 | Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts | Zusammensetzung einer Parvovirus VP1-Proteinvariante und eines arvovirus NS1-Proteins zur Induktion von Zytolyse |
-
2005
- 2005-09-23 DE DE602005020815T patent/DE602005020815D1/de not_active Expired - Lifetime
- 2005-09-23 AT AT05799042T patent/ATE465173T1/de active
- 2005-09-23 ES ES09174552.1T patent/ES2556710T3/es not_active Expired - Lifetime
- 2005-09-23 WO PCT/EP2005/054771 patent/WO2006032697A2/en not_active Ceased
- 2005-09-23 PL PL05799042T patent/PL1791858T3/pl unknown
- 2005-09-23 EP EP05799042A patent/EP1791858B1/de not_active Expired - Lifetime
- 2005-09-23 ES ES05799042T patent/ES2344739T3/es not_active Expired - Lifetime
- 2005-09-23 EP EP09174552.1A patent/EP2149583B1/de not_active Expired - Lifetime
- 2005-09-23 US US11/575,951 patent/US9573979B2/en not_active Expired - Fee Related
- 2005-09-23 PT PT05799042T patent/PT1791858E/pt unknown
-
2010
- 2010-07-13 CY CY20101100651T patent/CY1110185T1/el unknown
-
2017
- 2017-01-18 US US15/408,485 patent/US20170260239A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20170260239A1 (en) | 2017-09-14 |
| EP2149583A1 (de) | 2010-02-03 |
| WO2006032697A3 (en) | 2006-05-18 |
| EP1791858B1 (de) | 2010-04-21 |
| EP1791858A2 (de) | 2007-06-06 |
| US20070286870A1 (en) | 2007-12-13 |
| WO2006032697A2 (en) | 2006-03-30 |
| ES2344739T3 (es) | 2010-09-06 |
| EP2149583B1 (de) | 2015-10-28 |
| ES2556710T3 (es) | 2016-01-19 |
| DE602005020815D1 (de) | 2010-06-02 |
| PL1791858T3 (pl) | 2010-09-30 |
| PT1791858E (pt) | 2010-07-26 |
| US9573979B2 (en) | 2017-02-21 |
| CY1110185T1 (el) | 2015-01-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1110185T1 (el) | Τροποποιημενη πρωτεϊνη vp1-καψιδιου του παρβοϊου β19 | |
| ATE462006T1 (de) | Isoform des vegfs | |
| CY1111225T1 (el) | Νεα πεπτιδια ως αναστολεις πρωτεασης νs3-σερινης ιου ηπατiτιδας c | |
| NO20063624L (no) | FC region varianter | |
| IL180727A0 (en) | Antimicrobial peptides comprising an arginine and/or lysine -containing motif | |
| ATE471370T1 (de) | Varianten von beta-glukosidasen | |
| BR0307702A (pt) | Formulações de solução contendo anticorpo | |
| CY1108655T1 (el) | ΘΕΙΟΖΟΛΙΔΙΝ-4-ΟΝΕΣ ΓΙΑ ΤΗΝ ΑΝΑΣΤΟΛΗ ΠΡΩΤΕΪΝΩΝ hYAK3 | |
| DE60322188D1 (de) | Zytokin (zcytor17-ligand) | |
| DE60328092D1 (de) | Acetolactatsynthase codierende gene | |
| DE60137587D1 (de) | Antimikrobielle peptide und deren verwendung | |
| DE60332320D1 (de) | Neues screening-verfahren | |
| EP1801206A4 (de) | Verfahren zur herstellung von l-arginin, l-ornithin oder l-citrullin | |
| DK1608745T3 (da) | FVII eller FVIIa-Varianter | |
| DE60322613D1 (de) | Frostschutzproteine aus Basidiomyceten | |
| EA200600042A1 (ru) | Способы образования дисульфидных связей и гликозилирования белков и реагенты, применяемые в этих способах | |
| ATE324446T1 (de) | Mutante formen von etxb und ctxb und ihre verwendung als träger | |
| ATE527280T1 (de) | Fluoreszentprotein und chromoprotein | |
| EA200800098A1 (ru) | Экспрессионный вектор и способ продуцирования высоких уровней белков | |
| DK1602721T3 (da) | Phospholipase A SB 2 /SB stammende fra Koji-skimmelsvamp | |
| ATE511644T1 (de) | Neues screening-verfahren | |
| EP1801232A4 (de) | Verfahren zum screening eines transmembranenzymhemmstoffs | |
| EP1666880A4 (de) | Screening-verfahren | |
| EP1467207A4 (de) | Screening-verfahren | |
| ATE556135T1 (de) | Neues protein |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1791858 Country of ref document: EP |